bioRxiv Science⌕ Search

Biology subjects

dos Santos Lopes, V.

Publications and source records attributed to dos Santos Lopes, V..

2 recordsLinked to original sources

A Pan-Cancer Multi-Omic SuperLearner for Regulated Cell Death Survival Topologies

IntroductionRegulated cell death (RCD) pathways profoundly influence tumor progression and immune modulation. In prior work, we constructed a comprehensive database mapping 25 forms of RCD across seven multi-omic layers encompassing 33 tumor types (CancerRCDShiny). Despite their robust ability to identify risk populations, translating these prognostic signatures into personalized clinical workflows requires a shift from generalized cohort stratification to individualized risk mapping. This necessitates mapping the complex geometric landscape of patient risk--Survival Topologies--to accurately capture the non-linear dynamics of RCD signatures. MethodsWe engineered a Pan-Cancer Multi-Omic SuperLearner pipeline evaluating 33 cancer types. Phase I performed zero-leakage data harmonization and groupwise imputation to prevent cross-cohort amalgamation. Phase II utilized Elastic Net-regularized Cox (CoxNet) regression as an audit-compliant CANARY diagnostic to map mathematical proportional-hazards failures. Admissible strata enforcing a rigid 35% topological missingness barrier entered Phase III, deploying an advanced non-linear Quadripartite Base-Learner Ensemble (Random Survival Forests (RSF), Extreme Gradient Boosting (XGBoost), insulated Survival-Boruta, and Multi-Task Logistic Regression (MTLR))--fused within an Elastic Net Multi-View Meta-Learner (MVL)--with local interpretability guaranteed via post-hoc SHAPley Additive exPlanations (TreeSHAP) and Local Interpretable Model-agnostic Explanations (LIME). ResultsThe CANARY diagnostic empirically proved the structural invalidity of pan-cancer geometric proportional-hazards. Advancing 96 verified matrices into the Quadripartite Machine Learning Ensemble, Phase III executed a structural algorithmic displacement: dense continuous multi-omic topologies computationally suppressed static genomic mutations and Copy Number Variations (CNVs) during multidimensional competition (85.7% vs 0.0% apex retention). Furthermore, the MVL stabilized global predictions against extreme biological variance, while surrogate LIME validations (R{superscript 2} < 0.10) confirmed the absolute failure of linear interpretative proxies. Extracting N-dimensional TreeSHAP interactions natively bypassed generalized risk parameters, mapping exact Survival Topologies. This dynamically exposed multi-omic synergistic (lethal peaks) and antagonistic (protective valleys) rescue trajectories invisible to additive models. We integrated this architecture into CancerRCDPredictor, a Shiny application operating as a digital tumor board. ConclusionDeploying a Pan-Cancer Multi-Omic SuperLearner to bypass linear topological failures, this study advances beyond generalized cohort stratifications, establishing a deterministically mapped architecture for predicting RCD-related Survival Topologies. Through the CancerRCDPredictor interface, we directly translate multi-omic insights into individualized precision oncology interception.

bioinformatics↗

A Multi-Omic Atlas of Convergent and Divergent Metabolic Regulatory Circuitries in Cancer

Metabolic reprogramming underlies tumor progression, immune evasion, and resistance to regulated cell death, yet the higher-order regulatory logic that coordinates these processes across molecular layers remains poorly defined. We developed OncoMetabolismGPS, a multi-omic analytical framework that reconstructs a Pan-Cancer atlas of convergent and divergent metabolic regulatory circuitries. From 463,433 significant multi-omic and phenotypic associations across 33 tumor types, we derived 241,415 omic-specific metabolic signatures, each integrating metabolic pathway context with phenotypic, prognostic, and immune features. By mapping shared upstream regulators of these signatures, we identified 24,796 metabolic regulatory circuitries--classified as convergent when regulators and signatures act in the same biological direction, or divergent when they exhibit opposing associations. Divergent circuitry predominated, especially in immunosuppressive (cold) tumor contexts, revealing context-dependent regulatory compensation across metabolic, phenotypic, and clinical axes. The accompanying OncoMetabolismGPS Shiny application implements this atlas as an interactive platform that positions each signature and circuitry within a multidimensional coordinate space defined by molecular, phenotypic, immune, and clinical attributes, enabling systematic navigation of metabolic regulatory behavior in cancer. Together, this study establishes the first multi-omic atlas of metabolic regulatory circuitries, providing a conceptual and computational framework for dissecting metabolic plasticity, pathway dependencies, and therapeutic vulnerabilities across human cancers.

bioinformatics↗